Diagnostic performance of bone scintigraphy and 11C-Choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer

被引:15
|
作者
Garcia, J. R. [1 ]
Moreno, C. [1 ]
Valls, E. [1 ]
Cozar, P. [1 ]
Bassa, P. [1 ]
Soler, M. [1 ]
Alvarez-Moro, F. J. [1 ]
Moragas, M. [1 ]
Riera, E. [1 ]
机构
[1] Unidad PET CETIR ERESA, Barcelona, Spain
关键词
Bone scintigraphy; C-11-Choline PET/CT; Bone metastases; Biochemical recurrence; Prostate cancer; POSITRON-EMISSION-TOMOGRAPHY; CELL LUNG-CANCER; F-18-FLUORIDE PET; F-18-FDG PET/CT; DISEASE; SPECT; ONCOLOGY; RELAPSE; CT;
D O I
10.1016/j.remn.2014.08.001
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim: To compare bone scan (BS) with C-11-Choline PET/CT for the detection of bone metastases in patients with biochemical recurrence of prostate cancer (PC). Material and Methods: A total of 169 patients with biochemical recurrence of PC(PSA:2.4-58 ng/ml) who were referred for both exams (0-15 days-in-between) were included. Lesion-detection-rate per patients and lesions were analyzed for both BS and C-11-Choline PET/CT. Metastasis diagnosis was reached by: biopsy, CT/F-18-Fluoride PET/MRI confirmation, or evidence of progression in subsequent imaging procedures. Results: A total of 91 lesions were found to be active in BS and/or C-11-choline PET/CT (40 patients), with 78 of which were metastatic. BS detected 38 blastic, 2 lytic and 10 non-CT-evident lesions. C-11-Choline PET/CT detected 41 blastic, 4 lytic and 29 non-CT-evident lesions. BS and C-11-Choline PET/CT sensitivities were 65.4% and 96.1%; specificities ere 38.5 and 92.3% (chi(2) 8.27, p < 0.04). Both imaging techniques were negative in 118 patients. Tracer avid lesions were found in 51 patients: with 30/51 being BS and C-11-Choline PET/CT concordant; in 21/51 patients had discordant lesions (kappa 0.712, p = 0.00). Lesions were absolutely discordant in 10/19 patients,: 5 FN BS, 2 FP BS (degenerative changes: dysplasia), 1 FN C-11-Choline PET/CT (blastic), 1 FP C-11-Choline PET/CT (degenerative), 1 out of field-of-view lesion with C-11-Choline PET/CT (tibia alone). C-11-Choline PET/CT showed extraosseous involvement in 26/51 patients with bone metastases: 9 local recurrences, 5 infra-diaphragmatic-lymph-nodes, 2 supra-diaphragmatic, 5 local and infra-diaphragmatic, 4 infra- and supra-diaphragmatic, 1 supra-diaphragmatic and lung metastases. Conclusion: C-11-Choline PET/CT yielded better sensitivity and specificity than BS for the detection of bone involvement in patients with biochemical recurrence of PC and allowed extraosseous restaging, with an impact in the clinical management of these patients. (C) 2014 Elsevier Espana, S.L.U. and SEMNIM. All rights reserved.
引用
收藏
页码:155 / 161
页数:7
相关论文
共 50 条
  • [1] Diagnostic performance of 11C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer
    Kitajima, Kazuhiro
    Fukushima, Kazuhito
    Yamamoto, Shingo
    Kato, Takashi
    Odawara, Soichi
    Takaki, Haruyuki
    Fujiwara, Masayuki
    Yamakado, Koichiro
    Nakanishi, Yukako
    Kanematsu, Akihiro
    Nojima, Michio
    Hirota, Shozo
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2017, 79 (03): : 387 - 399
  • [2] 11C-Choline PET/CT in the Diagnostics of Bone Metastases in Prostate Cancer Patients with Biochemical Relapse
    Pursanova, D. M.
    Aslanidi, I. P.
    Mukhortova, O. V.
    Katunina, T. A.
    Shirokorad, V. I.
    Roschchin, D. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S700 - S701
  • [3] Good concordance between 11C-Choline PET-CT and bone scintigraphy for the detection of bone metastases from prostate cancer
    Garcia, Jose
    Riera, Eduard
    Soler, Marina
    Fuertes, Silvia
    Moragas, Gloria
    Moragas, Merce
    Carrio, Ignasi
    Lomena, Francisco
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [4] 11C-Choline PET/CT in Prostate Cancer Patients with Biochemical Recurrence
    Pursanova, D. M.
    Aslanidis, I. P.
    Mukhortova, O. V.
    Rumyantsev, A. S.
    Karyakin, O. B.
    Biryukov, V. A.
    Shirokorad, V. I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S668 - S668
  • [5] The value of 11C-Choline PET/CT versus 11C-Choline PET in the evaluation of patients with prostate cancer with suspicion of bone metastases
    Souvatzoglou, M.
    Tuncel, M.
    Herrman, K.
    Stollfuss, J.
    Schwaiger, M.
    Krause, B. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S209 - S209
  • [6] Comparison of bone scintigraphy and 11C-Choline PET/CT scans in skeletal metastases from prostate cancer
    Huntley, Ashley
    Chandler, Kimberly
    Hunt, Christopher
    Johnson, Geoffrey
    Peller, Patrick
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [7] Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients
    Beheshti, Mohsen
    Langsteger, Werner
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (05) : 910 - 911
  • [8] Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients
    Mohsen Beheshti
    Werner Langsteger
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 910 - 911
  • [9] Bone Metastases from Prostate Cancer 18F-Fluoride PET/CT in a Patient With Discordant Bone Scintigraphy and 11C-Choline PET/CT
    Garcia, Garzon, Jr.
    Riera, Eduard
    Valls, Eulalia
    Soler, Marina
    Bassa, Pere
    Moragas, Merce
    Lomena, Francisco
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (02) : 120 - 124
  • [10] Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy
    Chiara Fuccio
    Paolo Castellucci
    Riccardo Schiavina
    Ivan Santi
    Vincenzo Allegri
    Vincenzina Pettinato
    Stefano Boschi
    Giuseppe Martorana
    Adil Al-Nahhas
    Domenico Rubello
    Stefano Fanti
    Annals of Nuclear Medicine, 2010, 24 : 485 - 492